Clinical trial
Glioma: BIOMOLECULAR Aspects From Tissue to Radiomics
NCT05806619 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glioma: BIOMOLECULAR Aspects From Tissue to Radiomics
- Lead sponsor
- Regina Elena Cancer Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 22, 2019
- Completion date
- September 30, 2022
- Enrollment
- 150 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
glioma, malignant